Quantifying and Personalizing the Clinical Benefit of Metastasis-Directed Therapy in Men with De Novo Oligometastatic Prostate Cancer Grant

Overview

date/time interval

September 14, 2021 - August 31, 2028

awarded by

National Cancer Institute

administered by

Meyer Cancer Center

sponsor award ID

1 U01 CA257638-01

Affiliation

contributor

Barbieri, Christopher Principal Investigator (Subaward) 2021 - 2028